SINOPHARM(01099.HK)

Event Tracking

Jan1

Deadline for Sinopharm subsidiary's acquisition of Pai-lin Bio-pharmacy extended to June 30, 2026

11:52

Sinopharm Holdings receives consumer complaint regarding market-adjusted price issues

01:30

Sinopharm Holdings Renews Distribution Cooperation with Henlius for the Next Three Years, with a Total Cap Exceeding 12.2 Billion RMB

00:00

Dec31

Hubei Province Announces Non-Immunization Program Vaccine Distribution Companies, Including a Sinopharm Group Subsidiary

20:01

Sinopharm Commercializes First Domestic Quadrivalent HPV Vaccine

07:52

IPO Application of Kezhou Pharma, an Innovative Drug Company Deeply Tied to Sinopharm Holdings, Has Been Accepted

00:00

Schedules & Filings

Schedules

Filings

Oct21

Earning Release(CST)

FY2025 Q3 Earning Release (HKD) Revenue 158.99 B, Net Income 2.021 B, EPS 3.6093

Aug24

Earning Release(CST)

FY2025 Q2 Earning Release (HKD) Revenue 158.03 B, Net Income 2.19 B, EPS 0.6995

Aug22

Earning Release(CST)

FY2025 Semi-Annual Earning Release

Stock List

Top Gainers

Top Decliners

Main Board

Symbol

Price

%Chg

Change